Good morning, ProviderNation.
Talk about your devil and the deep blue sea options: It turns out, you may be able to duck the ravages of Alzheimer’s, and all you gotta do is get a lethal cancer.
A new study has found that those who had cancer and underwent chemotherapy were less likely to develop Alzheimer’s disease, Boston.com is saying.
Here’s Kay Lazar on the news:
“In the latest study, by the far the largest yet to establish a link, researchers at the VA Boston Healthcare System found that most types of cancer were associated with a reduced Alzheimer’s risk, with survivors of liver cancer having the most protection, a 51 percent reduced risk.
“Other apparently ‘protective’ cancers include those of the pancreas, a 44 percent reduced risk, esophagus, 33 percent, leukemia, 31 percent, lung, 25 percent, and kidney, 22 percent…”
Because this is Alzheimer’s, there’s a big ole caveat (natch): “Results from the study have not been published in a medical journal, meaning they have not undergone independent review by scientists not involved in the research,” Lazar says.
The findings were announced at an international Alzheimer’s conference in Boston earlier this week. “Another such victory,” Pyrrhus once said, “and I shall come back to Epirus alone.”